OR WAIT null SECS
August 02, 2022
Successful scale-up and BLA filings for products manufactured by microbial biomanufacturing require strategic planning.
April 02, 2022
The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.
November 23, 2021
Takeda has exercised an option to co-develop and co-commercialize an investigational, brain-penetrant progranulin replacement therapy for the potential treatment of frontotemporal dementia-granulin.
September 01, 2021
Mechanistic models provide process understanding for developing robust manufacturing processes and for scale up and tech transfer.
August 19, 2021
Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.
August 09, 2021
AGC Biologics has acquired Novartis’ Longmont, Colorado, manufacturing facility for the commercial production of cell and gene therapies.
July 21, 2021
Cellares has entered into a strategic relationship with Poseida Therapeutics to advance a closed, automated, and scalable cell therapy manufacturing system.
July 09, 2021
Sparx Therapeutics will build its first commercial manufacturing facility in Yangzhou, China, for antibody drug production.
June 08, 2021
VIVEbiotech has opened its new lentiviral vector manufacturing facilities in Spain, expanding capacity for lentiviral vectors for use in cell and gene therapies.
February 01, 2021
A unified scale-up approach, as presented here, can be applied to any unit operation.